NAPRIX D 5MG + 25MG CAP DURA CT FR PLAS OPC X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1003301780056
  • GGREM 523715070031403
  • Código de barras 7896094203259

O que a fonte publica

Detentor do registro
LIBBS FARMACÊUTICA LTDA
Princípios ativos
HIDROCLOROTIAZIDA;RAMIPRIL
Embalagem
5MG + 25MG CAP DURA CT FR PLAS OPC X 30
Tipo de produto
Novo
Classe terapêutica
C9B1 - INIBIDORES DA ECA ASSOCIADOS A ANTI-HIPERTERSIVOS (C2) E/OU DIURÉTICOS (C3)

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:523715070031403
{
  "name": "NAPRIX D 5MG + 25MG CAP DURA CT FR PLAS OPC X 30",
  "holder": "LIBBS FARMACÊUTICA LTDA",
  "stripe": null,
  "barcodes": [
    "7896094203259"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "523715070031403",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "61.230.314/0001-75",
  "priceRegime": "Regulado",
  "productName": "NAPRIX D",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "5MG + 25MG CAP DURA CT FR PLAS OPC X 30",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "47.03",
    "icms-12": "53.44",
    "icms-17": "56.66",
    "icms-18": "57.35",
    "icms-19": "58.06",
    "icms-20": "58.79",
    "icms-21": "59.53",
    "icms-22": "60.29",
    "icms-23": "61.08",
    "icms-17.5": "57.01",
    "icms-19.5": "58.42",
    "icms-20.5": "59.16",
    "icms-22.5": "60.68",
    "icms-12-alc": "52.80",
    "icms-17-alc": "55.98",
    "icms-18-alc": "56.67",
    "icms-19-alc": "57.36",
    "icms-20-alc": "58.08",
    "icms-21-alc": "58.82",
    "icms-22-alc": "59.57",
    "icms-23-alc": "60.34",
    "withoutTaxes": "46.47",
    "icms-17.5-alc": "56.32",
    "icms-19.5-alc": "57.72",
    "icms-20.5-alc": "58.45",
    "icms-22.5-alc": "59.96"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "HIDROCLOROTIAZIDA;RAMIPRIL",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "64.83",
    "icms-12": "73.66",
    "icms-17": "78.10",
    "icms-18": "79.05",
    "icms-19": "80.03",
    "icms-20": "81.04",
    "icms-21": "82.06",
    "icms-22": "83.10",
    "icms-23": "84.19",
    "icms-17.5": "78.58",
    "icms-19.5": "80.53",
    "icms-20.5": "81.55",
    "icms-22.5": "83.64",
    "icms-12-alc": "72.99",
    "icms-17-alc": "77.39",
    "icms-18-alc": "78.34",
    "icms-19-alc": "79.30",
    "icms-20-alc": "80.29",
    "icms-21-alc": "81.32",
    "icms-22-alc": "82.35",
    "icms-23-alc": "83.42",
    "withoutTaxes": "64.24",
    "icms-17.5-alc": "77.86",
    "icms-19.5-alc": "79.79",
    "icms-20.5-alc": "80.80",
    "icms-22.5-alc": "82.89"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "HIDROCLOROTIAZIDA",
    "RAMIPRIL"
  ],
  "therapeuticClass": "C9B1 - INIBIDORES DA ECA ASSOCIADOS A ANTI-HIPERTERSIVOS (C2) E/OU DIURÉTICOS (C3)",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1003301780056",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "C9B1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:523715070031403"